Locations
Cambridge, MA, USA · Medford, MA, USA · Cambridge, MA, USA · Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2017
Travera assists oncologists in selecting treatments for cancer patients through its Rapid Therapy Selection™ Test, which evaluates live cancer cells against a broad range of FDA-approved drugs. Utilizing a proprietary technology developed at MIT, the test provides results in just two days, offering a personalized approach to cancer treatment. With a growing catalog of over 100 drug options and a predictive accuracy of 80% in early studies, Travera aims to improve clinical outcomes for patients with late-stage cancers who have limited therapeutic options. The company has been conducting clinical studies at major medical institutions since 2018, establishing itself as a leader in cancer therapy guidance.
Something looks off?